CovidChloroV1, Main, Corpus, bibRecord, 001915

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Identifieur interne : 001915 ( Main/Corpus ); précédent : 001914; suivant : 001916

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Auteurs : Konstantinos Parperis

Source :

Annals of the rheumatic diseases [ 1468-2060 ] ; 2021.

RBID : pubmed:32321722

English descriptors

KwdEn :
- Antimalarials (therapeutic use), COVID-19 (MeSH), Humans (MeSH), Hydroxychloroquine (MeSH), Pandemics (prevention & control), SARS-CoV-2 (MeSH).
MESH :
- chemical , therapeutic use : Antimalarials.
- prevention & control : Pandemics.
- COVID-19, Humans, Hydroxychloroquine, SARS-CoV-2.

DOI: 10.1136/annrheumdis-2020-217557
PubMed: 32321722

Links to Exploration step

pubmed:32321722

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</title>
<author><name sortKey="Parperis, Konstantinos" sort="Parperis, Konstantinos" uniqKey="Parperis K" first="Konstantinos" last="Parperis">Konstantinos Parperis</name>
<affiliation><nlm:affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:32321722</idno>
<idno type="pmid">32321722</idno>
<idno type="doi">10.1136/annrheumdis-2020-217557</idno>
<idno type="wicri:Area/Main/Corpus">001915</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001915</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</title>
<author><name sortKey="Parperis, Konstantinos" sort="Parperis, Konstantinos" uniqKey="Parperis K" first="Konstantinos" last="Parperis">Konstantinos Parperis</name>
<affiliation><nlm:affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (therapeutic use)</term>
<term>COVID-19 (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32321722</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>80</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.</ArticleTitle>
<Pagination><MedlinePgn>e8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217557</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parperis</LastName>
<ForeName>Konstantinos</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">0000-0001-6009-0130</Identifier>
<AffiliationInfo><Affiliation>Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus kparpe02@ucy.ac.cy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Ann Rheum Dis. 2020 May;79(5):666-667</RefSource>
<PMID Version="1">32241791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Ann Rheum Dis. 2021 Jan;80(1):e9</RefSource>
<PMID Version="1">32366521</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="Y">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">arthritis</Keyword>
<Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">lupus erythematosus</Keyword>
<Keyword MajorTopicYN="Y">rheumatoid</Keyword>
<Keyword MajorTopicYN="Y">systemic</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32321722</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-217557</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-217557</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001915 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001915 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32321722
   |texte=   To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32321722" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki